New pill shows promise in preventing painful swelling attacks

NCT ID NCT02303626

Completed Disease control Sponsor: BioCryst Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study tested whether an oral medication called BCX4161 could safely prevent sudden swelling attacks in people with hereditary angioedema (HAE). For 12 weeks, 110 participants took either one of two doses of the pill or a placebo. Researchers measured how many attacks people had and how the treatment affected their daily life and safety.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Study site

Birmingham, Alabama, 35209, United States
Study site

Scottsdale, Arizona, 85251, United States
Study site

Granada Hills, California, 91344, United States
Study site

San Diego, California, 92093, United States
Study site

San Diego, California, 92112, United States
Study site

Walnut Creek, California, 94598, United States
Study site

Colorado Springs, Colorado, 80907, United States
Study site

Shreveport, Louisiana, 71106, United States
Study site

Chevy Chase, Maryland, 20815, United States
Study site

Boston, Massachusetts, 02114, United States
Study site

Plymouth, Minnesota, 55446, United States
Study site

St Louis, Missouri, 63141, United States
Study site

New York, New York, 10029, United States
Study site

Charlotte, North Carolina, 28277, United States
Study site

Cincinnati, Ohio, 45267, United States
Study site

Oklahoma City, Oklahoma, 73131, United States
Study site

Tulsa, Oklahoma, 74133, United States
Study site

Lake Oswego, Oregon, 97035, United States
Study site

Hershey, Pennsylvania, 17033, United States
Study site

Pittsburgh, Pennsylvania, 15241, United States
Study site

Dallas, Texas, 75231, United States
Study site

Galveston, Texas, 77555, United States
Study site

Fairfax, Virginia, 63141, United States
Study site

Spokane, Washington, 99204, United States
Study site

Tacoma, Washington, 98405, United States
Study site

Leuven, Belgium
Study site

Ottawa, Canada
Study site

Grenoble, France
Study site

Lille, France
Study site

Paris, France
Study site

Berlin, Germany
Study site

Frankfurt, Germany
Study site

Mörfelden-Walldorf, Germany
Study site

Budapest, Hungary
Study site

Milan, Italy
Study site

Birmingham, United Kingdom
Study site

Bristol, United Kingdom
Study site

Cardiff, United Kingdom
Study site

London, United Kingdom
Study site

Manchester, United Kingdom

Conditions

Explore the condition pages connected to this study.

HAE HEREDITARY ANGIOEDEMA